Novel molecular approaches to target microbial virulence /

Saved in:
Bibliographic Details
Author / Creator:Holban, Alina Maria.
Imprint:Warsaw ; Berlin : De Gruyter Open, [2015]
©2015
Description:1 online resource
Language:English
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/12646741
Hidden Bibliographic Details
Other authors / contributors:Grumezescu, Alexandru Mihai.
ISBN:9783110449501
3110449501
Digital file characteristics:text file PDF
Notes:Online resource; title from PDF title page (publisher's Web site, viewed Dec. 15, 2016).
Summary:Microbial infections still represent one of the major causes of mortality and morbidity worldwide. Irrational usage of antimicrobials has lead to increased resistance, causing clinical, social and economical disabilities. Therefore, one of the major challenges of scientists is to develop novel alternative methods to handle infections and reduce resistance and other side effects produced by the actual therapies. The aim of this book is to offer a perspective on novel approaches to handle infections by using naturally-derived products in order to modulate the virulence of pathogens, without the risk of developing resistance. We intend to highlight the utility of microbial, vegetal and animal-derived compounds with potential antimicrobial activity by exploiting their effect on microbial virulence. Furthermore, this book aims to reveal the potential to assimilate recent bio-technological findings, like the usage of nanotechnology as efficient shuttles for stabilizing, improved targeting and the controlled release of natural products in order to efficiently fight infections.
Other form:print 9783110449495
Standard no.:10.1515/9783110449501

MARC

LEADER 00000cam a2200000Mi 4500
001 12646741
005 20220624111547.0
006 m o d
007 cr |||||||||||
008 151110s2015 gw ob 000 0 eng d
019 |a 980262946 
020 |a 9783110449501 
020 |a 3110449501 
024 7 |a 10.1515/9783110449501  |2 doi 
035 |a (OCoLC)979955189  |z (OCoLC)980262946 
035 9 |a (OCLCCM-CC)979955189 
040 |a DEGRU  |b eng  |e rda  |e pn  |c DEGRU  |d OCLCQ  |d OCLCO  |d OCLCF  |d VT2  |d OCLCQ  |d UKAHL  |d SFB  |d OCLCO  |d OCLCA  |d OCLCO 
049 |a MAIN 
050 4 |a RM267 
072 7 |a MED052000  |2 bisacsh 
072 7 |a SCI045000  |2 bisacsh 
072 7 |a SCI050000  |2 bisacsh 
072 7 |a TEC027000  |2 bisacsh 
100 1 |a Holban, Alina Maria. 
245 1 0 |a Novel molecular approaches to target microbial virulence /  |c Alina Maria Holban, Alexandru Mihai Grumezescu. 
264 1 |a Warsaw ;  |a Berlin :  |b De Gruyter Open,  |c [2015] 
264 4 |c ©2015 
300 |a 1 online resource 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 0 |t Frontmatter --  |t Contents --  |t Preface --  |t 1 Introduction --  |t 2 Microbial Virulence --  |t 3 Alternative Methods for Infection Control --  |t 4 Increasing the Efficiency of Antimicrobial Compounds Using Nanotechnology --  |t 5 Conclusions and Perspectives --  |t Acknowledgements --  |t Bibliography --  |t List of Figures --  |t List of Tables --  |t Index 
588 0 |a Online resource; title from PDF title page (publisher's Web site, viewed Dec. 15, 2016). 
520 |a Microbial infections still represent one of the major causes of mortality and morbidity worldwide. Irrational usage of antimicrobials has lead to increased resistance, causing clinical, social and economical disabilities. Therefore, one of the major challenges of scientists is to develop novel alternative methods to handle infections and reduce resistance and other side effects produced by the actual therapies. The aim of this book is to offer a perspective on novel approaches to handle infections by using naturally-derived products in order to modulate the virulence of pathogens, without the risk of developing resistance. We intend to highlight the utility of microbial, vegetal and animal-derived compounds with potential antimicrobial activity by exploiting their effect on microbial virulence. Furthermore, this book aims to reveal the potential to assimilate recent bio-technological findings, like the usage of nanotechnology as efficient shuttles for stabilizing, improved targeting and the controlled release of natural products in order to efficiently fight infections. 
650 0 |a Biotechnology.  |0 http://id.loc.gov/authorities/subjects/sh85014263 
650 0 |a Infectious and parasitic diseases. 
650 0 |a Microbiology.  |0 http://id.loc.gov/authorities/subjects/sh85084783 
650 0 |a Nanotechnology.  |0 http://id.loc.gov/authorities/subjects/sh91001490 
650 0 |a Bacterial diseases.  |0 http://id.loc.gov/authorities/subjects/sh85010843 
650 0 |a Physical sciences.  |0 http://id.loc.gov/authorities/subjects/sh89005705 
650 0 |a Toxins.  |0 http://id.loc.gov/authorities/subjects/sh85136335 
650 0 |a Anti-infective agents.  |0 http://id.loc.gov/authorities/subjects/sh85005613 
650 0 |a Microelectronics.  |0 http://id.loc.gov/authorities/subjects/sh85084822 
650 0 |a Technology.  |0 http://id.loc.gov/authorities/subjects/sh85133147 
650 0 |a Diseases.  |0 http://id.loc.gov/authorities/subjects/sh85038411 
650 2 |a Anti-Bacterial Agents 
650 2 |a Virulence Factors  |0 https://id.nlm.nih.gov/mesh/D037521 
650 2 |a Nanotechnology  |0 https://id.nlm.nih.gov/mesh/D036103 
650 2 |a Bacterial Infections 
650 2 |a Natural Science Disciplines 
650 2 |a Toxins, Biological  |0 https://id.nlm.nih.gov/mesh/D014118 
650 2 |a Anti-Infective Agents  |0 https://id.nlm.nih.gov/mesh/D000890 
650 2 |a Bacterial Infections and Mycoses. 
650 2 |a Miniaturization  |0 https://id.nlm.nih.gov/mesh/D008904 
650 2 |a Technology 
650 2 |a Disease  |0 https://id.nlm.nih.gov/mesh/D004194 
650 2 |a Disciplines and Occupations. 
650 2 |a Biological Factors  |0 https://id.nlm.nih.gov/mesh/D001685 
650 2 |a Therapeutic Uses. 
650 2 |a Chemicals and Drugs. 
650 2 |a Technology, Industry, and Agriculture. 
650 2 |a Pharmacologic Actions. 
650 2 |a Chemical Actions and Uses. 
650 2 |a Technology, Industry, Agriculture. 
650 2 |a Biotechnology  |0 https://id.nlm.nih.gov/mesh/D001709 
650 2 |a Microbiology  |0 https://id.nlm.nih.gov/mesh/D008829 
650 6 |a Biotechnologie. 
650 6 |a Microbiologie. 
650 6 |a Nanotechnologie. 
650 6 |a Maladies bactériennes. 
650 6 |a Sciences physiques. 
650 6 |a Toxines. 
650 6 |a Antiinfectieux. 
650 6 |a Microélectronique. 
650 6 |a Technologie. 
650 6 |a Maladies. 
650 6 |a Produits biologiques. 
650 7 |a bioengineering.  |2 aat 
650 7 |a microbiology.  |2 aat 
650 7 |a physical sciences.  |2 aat 
650 7 |a microelectronics.  |2 aat 
650 7 |a Biotechnology.  |2 fast  |0 (OCoLC)fst00832729 
650 7 |a Microbiology.  |2 fast  |0 (OCoLC)fst01019576 
650 7 |a Pharmacy, Therapeutics, & Pharmacology.  |2 hilcc 
650 7 |a Health & Biological Sciences.  |2 hilcc 
700 1 |a Grumezescu, Alexandru Mihai. 
776 0 |c print  |z 9783110449495 
856 4 0 |u https://directory.doabooks.org/handle/20.500.12854/54879  |y Open Access Publishing in European Networks 
903 |a HeVa 
929 |a oclccm 
999 f f |i d180905c-247a-5b77-a5bf-503e660aa23d  |s 7a9cb731-ec48-5675-83e4-f649b4d2fd55 
928 |t Library of Congress classification  |a RM267  |l Online  |c UC-FullText  |u https://directory.doabooks.org/handle/20.500.12854/54879  |z Open Access Publishing in European Networks  |g ebooks  |i 12695267